A Potential Marker for Predicting No-Reflow in Non-ST-Elevation Myocardial Infarction (NSTEMI)

Abstract

Get full access to this article

View all access options for this article.

References

Nurkoç

Karayiğit

. The Association between no-reflow and serum uric acid/albumin ratio in patients with acute myocardial infarction without ST elevation. Angiology 2024;75:72-78.

Byrne

Rossello

Coughlan

, et al. ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44:3720-3826.

Wallentin

Becker

Budaj

, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057.

Wiviott

Braunwald

McCabe

, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-2015.

Park

Cho

Y-R

Park

J-S

, et al. Comparison of the effects of ticagrelor and clopidogrel on microvascular dysfunction in patients with acute coronary syndrome using invasive physiologic indices. Circ Cardiovasc Interv 2019;12:e008105.

Dai

, et al. Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Drug Des Dev Ther 2018;12:2039-2049.